Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Parkinson'S Disease|March 12, 2013
Methamphetamine and Parkinson's diseaseNoelia Granado, Sara Ares-Santos, Rosario MoratallaNeurotoxicity Research|June 24, 2018
Striatal Reinnervation Process after Acute Methamphetamine-Induced Dopaminergic Degeneration in MiceNoelia Granado, Sara Ares-Santos, Yousef Tizabi, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 31, 2013
Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver stainingSara Ares-Santos, Noelia Granado, Isabel Espadas, et al.Neurotoxicity Research|December 11, 2014
Methamphetamine-induced toxicity in indusium griseum of mice is associated with astro- and microgliosisAna Carmena, Noelia Granado, Sara Ares-Santos, et al.Neurotoxicity Research|September 18, 2009
Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration : early loss of TH in striosomes after methamphetamineNoelia Granado, Sara Ares-Santos, Esther O'Shea, et al.Glia|September 2, 2011
Nrf2 deficiency potentiates methamphetamine-induced dopaminergic axonal damage and gliosis in the striatumNoelia Granado, Isabel Lastres-Becker, Sara Ares-Santos, et al.Neurobiology of Disease|February 10, 2011
Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMANoelia Granado, Sara Ares-Santos, Idaira Oliva, et al.Pageof 1